All lobbying filings

Steptoe LLP

Steptoe LLP filed a Q2 termination report for Aquestive Therapeutics, Inc. on July 21, 2025, reporting $30,000 in lobbying income.

Lobbying for Aquestive Therapeutics, Inc. · Pharmaceutical

As filed: STEPTOE LLP for AQUESTIVE THERAPEUTICS, INC.

All filings by Steptoe LLP · Everything Aquestive Therapeutics, Inc. has reported

Filing · LD-2 quarterly report Q2 termination

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 21, 2025

Income

$30,000

What the client paid this registrant for the period.

Client based in

New Jersey

Representation ended

Apr 22, 2025

The registrant reported terminating its work for this client.

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Issues related to the FDA and the Orphan Drug Program.

Pharmacy

Issues related to the FDA and the Orphan Drug Program.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.